Old drug gets an absurd price hike to $89,000 per year
On February 12, 2017 by Michelle Turner With 0 Comments
- Tech
Martin Shkreli doesn't have a monopoly on jacking up drug prices. Marathon Pharmaceuticals has received FDA approval for an old drug used to treat Duchenne muscular dystrophy, deflazacort, and in the process has raised the price to ridiculously high…
Engadget RSS Feed
Comments are Disabled